U.S. Health Secretary Robert F. Kennedy Jr. declared that COVID-19 vaccines would no longer be routinely recommended for pregnant women and healthy children, bypassing the CDC’s standard advisory process...
After a close inspection of its active pharmaceutical ingredient (API) manufacturing unit, Dr. Reddy’s Laboratories has received a Form 483 with two observations from the US Food and Drug Administration (USFDA)...
A panel of advisers to the U.S. Food and Drug Administration (FDA) unanimously recommended that COVID-19 vaccines for the 2025–26 season target updated strains of the JN.1 variant, and particularly...
FedEx Corp. (NYSE: FDX) has gained recognition from the International Air Transport Association (IATA) through its CEIV Pharma Corporate Certification which values its strong commitment to handling pharmaceuticals well across the world...
India’s Implant Market to Reach USD 5 Billion by FY28 on Strong DemandIndia's orthopaedic and cardiac implant industry is likely to grow to USD 4.5–5 billion by FY2027-28, almost twice the size it is today at USD 2.4–2.7 billion in FY24...
US President Donald Trump’s new price range for Rx drugs with other developed countries might not affect the generic companies in India.
JB Pharma is making significant strides in the fight against hypertension and its impact on kidney health, in India. On the occasion of the upcoming ‘World Hypertension Day’ celebrated on 17th May
The net profit of Glaxosmithkline pharmaceuticals has been raised to 34.73 percent in the quarter of March 2025.
U.S. President Donald Trump’s latest administrative order pointing to cut domestic drug prices could wave across global pharmaceutical markets, with certain pressure on India to raise prices.
India’s pharmaceutical sector is feeling the heat after U.S. President Donald Trump unveiled a bold plan to cut drug prices by 30-80%. This policy, aimed at making U.S. drug costs match lower prices in other countries, could shake up the 9 billio...
, CDSCO.jpg)
